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Background: Co-morbidity between Type 1 Diabetes Mellitus (T1DM) and eating disorders (ED) has been previously
described; however the effect of this illness on the outcomes for conventional ED treatments has not been previously
investigated. This study aims to compare clinical, psychopathological and personality features between two samples of
ED individuals: those with comorbid T1DM and those without (No-DM); and to identify differences in treatment
outcomes between the groups.
Methods: This study compares treatment outcome, dropouts, ED psychopathology and personality characteristics for
20 individuals with ED and T1DM and 20 ED patients without diabetes, matched for diagnostic and treatment type.
Results: The study found higher dropout rates from therapy in individuals with T1DM and worse treatment outcome
in spite of having no significant differences in eating disorder psychopathology, although individuals with T1DM report
misusing insulin.
Conclusions: The low levels of motivation to change, and insulin abuse in T1DM patients, may suggest that treatment
for patients with ED and T1DM should consider the individual’s personality and role of insulin abuse when determining
the appropriate intervention.
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The onset of Type I Diabetes Mellitus (T1DM) is usually
associated with initial weight loss but insulin initiation
and correct compliance can increase body mass index
[BMI (Kg/m2)]. Research has found that T1DM is asso-
ciated with high BMI, especially in young females [1].
Some of the weight increase may be associated with binge
episodes triggered by hunger due to hypoglycaemia. Thus,
T1DM individuals may be a susceptible population to de-
velop overconcern about weight and shape, body dissatis-
faction, food preoccupation, active dietary restraint and
even disturbed eating behaviors. This may explain why* Correspondence: ffernandez@bellvitgehospital.cat
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unless otherwise stated.T1DM individuals are at risk of developing certain eating
disorders (ED), particularly bulimia nervosa [2].
ED in T1DM individuals can be manifested by weight-
control practices that include fasting, vomiting, laxative
and diuretic abuse, but also intentional insulin omission
or under-dosing causing weight loss [2-4]. ED in T1DM
has been associated with impaired metabolic control, more
frequent episodes of ketoacidosis and an earlier-than-
expected onset of microvascular complications [5].
In spite of this, current treatments for individuals with
ED do not vary depending on whether the person suffers
from T1DM or not, although the clinical and personality
characteristics may differ. Research examining the per-
sonality characteristics and temperament profile in the
field of eating disorders has identified that certain eating
disorders, such as bulimia nervosa (BN) purging type,
are included in the maladaptive profile, particularly
related to impulsivity, which will be associated with
high dropouts. In addition restrictive symptomatology istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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study has included eating disorder independent of their
medical comorbidity, such as diabetes. With this in mind
this study aims: a) to compare clinical, psychopathological
and personality features between two samples of ED indi-
viduals: those with comorbid T1DM (T1DM) and those
without (No-DM); and b) to identify differences in treat-
ment outcomes between the groups.
Methods
Participants
From an initial sample of 1887 patients diagnosed with
ED according to the DSM-IV [7] at the Eating Disorder
Unit of the Bellvitge Hospital (Barcelona, Spain) between
April 1999 and June 2012, 20 subjects with comorbid
T1DM were identified (1.06% of total ED cases). Subjects
suffering from T1DM were matched with 20 individuals
without diabetes from the same pool of ED patients for
socio-demographic variables (age, marital status, catch-
ment area and education level), age of onset and diagnosis.
Exclusion criteria were: (a) patients aged <18 years old;
(b) males, as their number was too small for meaningful
comparisons; (c) a T1DM diagnosis of less than 6 months
before inclusion into the study; (d) patients diagnosed
with other type of diabetes. In order to aid the interpret-
ation of the results and make it relevant to the current
DSM-5 diagnosis, the EDNOS category will be divided into
patients with sub-threshold AN (who fulfill the diagnosis
of AN under the new DSM-5), patients with sub-threshold
BN (who fulfill the diagnosis of BN under the new DSM-5)
and patients with “Pure” EDNOS.
Assessment
Clinical information and diagnosis was obtained through
a semi-structured interview conducted by experienced
psychologists and psychiatrists. Patients completed a bat-
tery of psychological questionnaires, which included the
Temperament and Character Inventory–revised (TCI-R)
[8] and the Eating Disorders Inventory-2 (EDI-2) [9]. The
motivational stage of change was assessed through a visual
analogue scale, described elsewhere [10]. Anthropometric
measures (weight and height), glycaemic control and insu-
lin adherence were assessed during a scheduled face-
to-face medical visit. For T1DM patients, the glycated
hemoglobin (HbA1c) measured nearest to the interview
was used as an indicator of glycaemic control. Insulin
misuse was identified if patients admitted to manipulat-
ing or omitting their insulin dose as a purging method.
Following assessment and diagnosis, patients received
treatment as usual: 16 sessions of cognitive-behavioural
therapy (CBT) outpatient treatment for those with BN,
binge eating disorder (BED) and eating disorder not
otherwise specified (EDNOS), and 3 months day
hospitalization for anorexia nervosa (AN) patients[11,12]. Patients were re-evaluated at the end of their
treatment and categorized as: total remission, partial
remission and no remission defined as per previous
studies [12] and voluntary treatment discontinuation
(dropouts). The Ethics Committee of our institution
(Ethics Committee of Clinical Research of the University
Hospital of Bellvitge) approved the study. Written in-
formed consent was obtained from all participants.
Statistical analysis
All statistical analyses were conducted using the Statis-
tical Package for the Social Sciences, SPSS version 20.0
for Windows. T-TEST procedures compared quantita-
tive clinical outcomes between ED patients with and
without diabetes, and binary logistic regressions com-
pared categorical clinical outcomes. Survival analysis
modeled time to therapy dropout, Breslow chi-square
test compared survival cumulative functions for patients
with and without diabetes. All the models were adjusted
for the variables of BMI and ED diagnostic subtype. A
p-value of <0.05 was considered statistically significant.
Effect-size analyses were performed using Cohen’s d,
which represents the mean difference score between
two groups. A Cohen’s d score <0’3 was considered
small, >0’3 and <0’8 medium and >0’8 large.
Results
No statistical differences were found between the two
clinical groups for any socio-demographic variable.
Mean age for T1DM patients was 25.3 years (SD = 8.0)
and for No-DM 28.0 (SD = 8.4). Age of onset of ED was
19.5 years (SD = 7.4) for T1DM and 19.4 (SD = 7.5) for
No-DM. ED diagnostic distribution was: 10.0% “AN and
sub-threshold AN”, 25.0% “BN and sub-threshold BN”,
10% BED and 55% “pure” EDNOS (the same distribution
for the both groups, for T1DM and for No-DM, as they
were matched on this variable). For T1DM patients,
the mean age of the diabetes diagnosis was 15.1 years
(SD = 6.2, interquartile range from 10.5 to 17 years) and
the mean duration of the illness was 10.3 years (SD = 8.2,
interquartile range from 3 to 15 years). In this group of pa-
tients, mean HbA1c was 9.94% (SD = 3.00) (normal range
4.5-6%) at baseline.
T1DM used insulin manipulation to control weight
as most of them (n = 18, 90%) acknowledged skipping
or reducing insulin doses. Prior ED onset, poor self-
monitoring of glycaemic control characterized these
T1DM subjects. Except for insulin misuse, there were no
statistical differences between the two clinical groups for
any other eating disorder related behaviour and psycho-
pathology (see Table 1). No differences were found in the
frequency of bingeing or diuretic abuse. However, al-
though not statistically significant, use of vomiting and
laxative abuse was more prevalent in the No-DM group.
Table 1 Comparison for clinical, motivational and personality traits at baseline between the two clinical groups (N = 40)
Mean – standard deviation Mean comparisons and Cohen’s-d
No-DM With T1DM p Mean
diff.
95% CI (mean differ.) | d |
(n = 20) (n = 20)
Binges per week 4.10 6.46 3.71 6.98 .860 −0.39 −4.88 4.09 0.06
Vomits per week 4.80 9.43 1.65 3.77 .205 −3.15 −8.11 1.80 0.44
Laxatives per week 5.20 15.71 0.82 3.40 .269 −4.38 −12.28 3.53 0.39
Diuretics per week 1.05 4.70 0.44 1.75 .625 −0.61 −3.13 1.91 0.17
Body mass index (kg/m2) 22.59 6.23 23.34 6.35 .722 0.75 −3.51 5.02 0.12
Perceived Intensity of ED 5.85 2.03 4.35 2.11 .028* −1.50 −2.83 −0.17 0.72*
Need for treatment 5.90 2.40 5.30 2.41 .435 −0.60 −2.14 0.94 0.25
Impairment 5.50 2.26 3.65 2.66 .023* −1.85 −3.43 −0.27 0.75*
Worry (self) 6.45 1.99 5.55 2.96 .266 −0.90 −2.52 0.72 0.36
EDI: Drive for thinness 13.11 6.00 12.15 5.40 .604 −0.96 −4.66 2.75 0.17
EDI: Body dissatisfaction 15.47 7.81 15.45 8.78 .993 −0.02 −5.42 5.38 0.00
EDI: Interoceptive awareness 14.11 7.74 9.50 6.82 .056 −4.61 −9.33 0.12 0.63*
EDI: Bulimia 5.58 5.90 5.70 5.70 .948 0.12 −3.64 3.89 0.02
EDI: Interpersonal distrust 6.68 3.51 5.75 4.66 .486 −0.93 −3.62 1.75 0.23
EDI: Ineffectiveness 11.21 7.07 10.90 7.91 .898 −0.31 −5.19 4.56 0.04
EDI: Maturity fears 6.74 5.59 8.75 5.22 .252 2.01 −1.49 5.52 0.37
EDI: Perfectionism 6.21 3.60 5.45 5.22 .601 −0.76 −3.68 2.16 0.17
EDI: Impulse regulation 7.32 4.66 7.55 7.07 .904 0.23 −3.67 4.14 0.04
EDI: Asceticism 6.63 4.18 6.60 4.31 .982 −0.03 −2.79 2.72 0.01
EDI: Social insecurity 8.42 4.26 8.95 6.39 .764 0.53 −3.01 4.07 0.10
EDI: Total score 101.47 39.10 96.75 48.80 .741 −4.72 −33.51 24.06 0.11
TCI-R: Novelty seeking 103.05 12.78 101.79 16.65 .795 −1.26 −11.03 8.50 0.09
TCI-R: Harm avoidance 118.32 15.11 115.42 21.43 .633 −2.89 −15.10 9.31 0.16
TCI-R: Reward dependence 105.32 12.52 101.84 16.94 .477 −3.47 −13.27 6.33 0.23
TCI-R: Persistence 119.47 22.68 101.16 29.31 .038* −18.32 −35.56 −1.07 0.70*
TCI-R: Self-directedness 114.37 19.82 116.47 23.78 .769 2.11 −12.30 16.51 0.10
TCI-R: Cooperativeness 136.16 13.31 136.79 12.83 .882 0.63 −7.97 9.23 0.05
TCI-R: Self-Transcendence 68.95 14.50 65.84 12.16 .479 −3.11 −11.91 5.70 0.23
*Bold: significant comparison (.05 level). *Bold: moderate to high effect size (|d| ≥ 0.5).
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DM, to self-harm (p < .012; d:1.03), have suicidal ideation
(p < .030; d:0.80) and suicidal behaviour (p < .039; d:0.79)
(see Additional file 1: Table S1).
T1DM group scored significantly lower on motivation
to change and level of consciousness about their ED
(less self-perceived intensity of the ED and less perceived
impairment). The only personality trait with a significant
difference was persistence, which showed lower scores
in T1DM (participants were characterized by low perse-
verance, instability, giving up easily when confronted
with frustration and with low accomplishment levels)
than No-DM, and were lower than normative population
scores [13].Treatment outcome
Three quarters of No-DM group (n = 15) showed partial
or full remission when compared to 50% (n = 10) of
T1DM group (see Additional file 1: Tables S2-S3). The
dropout number was higher among T1DM patients
when compared to No-DM. Although the difference was
not statistically significant, a Cohen’s d value of 0.53
shows at least 79% of the T1DM patients were higher
dropout risks than the average non-diabetic patient.
T1DM patients stopped treatment significantly earlier
(χ2 = 4.50, df = 1, p = .034). From 50% of the patients that
stopped treatment, 30% did so after the first session,
15% after the 4th, 5% after the 6th, and the rest after ses-
sion 10. Patients without diabetes dropped out later on
Figure 1 Cumulative survival.
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with lower motivation to change (both lower need of
treatment, r = −.30, p < .05) and perceived intensity of
ED (r = −.32, p < .05). No statistical differences, due to
ED subtype, were found for the risk of dropout or
partial-total remission in the No-DM patients (p = .284
and p = .523) and the T1DM group (p = .286 and p = .523)
(Additional file 1: Table S2).
Discussion
The aim of the study was to identify clinical differences
and treatment outcome between individuals with eating
disorders and T1DM and those without diabetes. Eating
disorders, particularly BN has been previous associated
to T1DM [2-5]. The association between both condi-
tions is so clear that a new term, which is not yet a med-
ically recognized condition, has recently been described
in the literature, Diabulimia. This condition has been
particularly described among the adolescent population,
as weight management during this time of development
for individuals with diabetes can be particularly difficult
forcing them to restrict or omit insulin [14]. Our study
confirms the misuse of insulin among this population.
The lack of difference in purging behavior and the
differences in self-harm and suicidal behaviour between
the two groups may point towards the importance of
analyzing the role of insulin misuse in this population.
For example, the lower number of self-harm behaviours
in patients with T1DM may indicate that patients with
this condition may not require the use of self-harm in
order to deal with emotions as they may use insulin mis-
use instead. It can be hypothesized that insulin omission,
which leads to weight loss, is more closely connected to
mood regulation and self-harm behaviour than to weight
and shape issues, although this will need to be researchedfurther. This could explain the difficulties that T1DM pa-
tients may have in stopping insulin abuse, as recently noted
[4], and the poor motivation of these individuals as mani-
fested by high number of treatment dropouts found in this
study.
ED patients with T1DM were found to dropout more
frequently and sooner than patients without diabetes.
The study found that treatment outcome for T1DM
patients was overall worse than for individuals without
diabetes. Motivation levels and personality traits (low
persistence and accomplishment levels), could explain
these results, as suggested in studies with DM patients
[15]. The fact that individuals with T1DM present with
low persistence which is associated to low frustration
tolerance and low perseverance may explain the high
levels of dropouts and the poor outcomes found among
these individuals. That and will suggest the need for in-
terventions to be modified for this population and for
diabetologies to be informed about the risk of poor out-
come that patients with both conditions present. The
lack of motivation for change found among individuals
with T1DM may also be a reflection of the low levels of
consciousness regarding the illness, the low perceived
intensity and low perceived impairment which suggests
the importance of working using Motivational Enhance-
ment interventions with individuals with T1DM and ED.
Although there is clear evidence that T1DM are par-
ticularly associated with BN [2,5], this study has in-
cluded all type of eating disorders. Future studies may
want to focus in exploring the outcome of patients
with T1DM and BN only. Moreover, future studies may
also want to consider investigating whether the pres-
ence of comorbid diabetes impacts motivation to
treatment per se. Although the study is limited by
sample size, the patient’s reliability about self-reporting
insulin underdosing and the possible influence of
T1DM on ED questionnaires [16], the current study
has addressed treatment response and dropout rates of
CBT therapy across the ED patients with T1DM which,
to our knowledge, has not been previously investigated.
Conclusions
The low levels of motivation to change, and insulin
abuse in T1DM patients, may suggest that treatment for
patients with ED and T1DM should consider the indi-
vidual’s personality and role of insulin abuse when deter-
mining the appropriate intervention.Additional file
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Comparison for therapy outcomes between ED with and without T1DM.
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